Claus Steensen Sølje

Largest profit: Novo Nordisk Pharmatech A/S (2017) '103,665 DKK

Most equity: Novo Nordisk Pharmatech A/S (2017) '528,953 DKK

• UVH A/S

  Active

  
  

  Board member (2024-05-31 - present)

• INGENIØR JOHANNES HANSENS FOND

  Active

  
  

  Ultimate beneficial owner (2023-06-01 - present)

• CKIOA Holding ApS

  Active

  
  

  Director (2024-02-28 - present)

  Legal owner (2024-02-28 - present) 100% ownership (2024-02-28 – ) 100% voting rights (2024-02-28 – )

  Ultimate beneficial owner (2024-02-28 - present) 100% ownership (2024-02-28 – ) 100% voting rights (2024-02-28 – )

• Novo Nordisk Pharmatech A/S

  Active

  
  

  Board member (2017-01-27 - 2020-03-18)

• NOVO NORDISK PHARMA OPERATIONS A/S

  Active

  
  

  Board member (2017-04-25 - 2023-06-01)

  Director (2013-09-01 - 2017-04-25)

• ALK-ABELLÓ NORDIC A/S

  Active

  
  

  Board member (2023-06-01 - present)